Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$15.07 USD
-0.01 (-0.07%)
Updated May 28, 2024 04:00 PM ET
After-Market: $14.78 -0.29 (-1.92%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Assembly Biosciences, Inc. [ASMB]
Reports for Purchase
Showing records 21 - 24 ( 24 total )
Company: Assembly Biosciences, Inc.
Industry: Medical - Generic Drugs
3Q21 Recap; Interim Data From All Three VBR Triple Combination Studies Expected in 2022; Maintain Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Assembly Biosciences, Inc.
Industry: Medical - Generic Drugs
Antios Clinical Collaboration to Evaluate Vebicorvir As Part of All-Oral Triple Combo For HBV; Maintain Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Assembly Biosciences, Inc.
Industry: Medical - Generic Drugs
Company: Assembly Biosciences, Inc.
Industry: Medical - Generic Drugs
We Believe in Core Inhibitors'' Role in a Finite HBV Therapy But Cannot Overlook Recent Setbacks; Initiate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E